DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,600,733 | +3.4% | 6,452 | 0.0% | 0.18% | +5.1% |
| Q2 2023 | $1,548,395 | -6.5% | 6,452 | -1.9% | 0.18% | +1.1% |
| Q1 2023 | $1,656,838 | +99052.5% | 6,574 | +4.4% | 0.17% | -1.7% |
| Q4 2022 | $1,671 | -99.9% | 6,298 | -1.9% | 0.18% | -10.6% |
| Q3 2022 | $1,658,000 | +2.7% | 6,418 | +0.8% | 0.20% | +10.0% |
| Q2 2022 | $1,614,000 | -61.0% | 6,367 | -52.0% | 0.18% | -10.9% |
| Q1 2022 | $4,142,000 | +81.9% | 13,276 | +91.8% | 0.20% | -10.2% |
| Q4 2021 | $2,277,000 | +11.1% | 6,920 | +2.8% | 0.22% | -3.8% |
| Q3 2021 | $2,049,000 | +49.7% | 6,729 | +10.6% | 0.23% | +18.2% |
| Q2 2021 | $1,369,000 | 0.0% | 6,082 | 0.0% | 0.20% | -19.5% |
| Q1 2021 | $1,369,000 | -1.7% | 6,082 | +3.9% | 0.25% | -10.9% |
| Q4 2020 | $1,393,000 | +47.9% | 5,853 | -14.0% | 0.28% | -17.9% |
| Q1 2020 | $942,000 | -9.9% | 6,806 | 0.0% | 0.34% | +16.7% |
| Q4 2019 | $1,045,000 | +6.3% | 6,806 | 0.0% | 0.29% | -9.1% |
| Q3 2019 | $983,000 | +1.3% | 6,806 | +0.3% | 0.32% | +10.8% |
| Q2 2019 | $970,000 | +8.3% | 6,788 | 0.0% | 0.29% | +5.5% |
| Q1 2019 | $896,000 | +23.8% | 6,788 | -3.3% | 0.27% | +22.1% |
| Q4 2018 | $724,000 | -12.6% | 7,023 | -7.9% | 0.22% | +22.0% |
| Q3 2018 | $828,000 | +10.1% | 7,623 | 0.0% | 0.18% | +0.6% |
| Q2 2018 | $752,000 | +3.7% | 7,623 | +2.9% | 0.18% | +27.5% |
| Q1 2018 | $725,000 | +76.8% | 7,405 | +54.6% | 0.14% | +51.1% |
| Q1 2017 | $410,000 | -4.9% | 4,791 | -13.4% | 0.09% | +2.2% |
| Q4 2016 | $431,000 | +12.5% | 5,535 | +13.3% | 0.09% | +1.1% |
| Q3 2016 | $383,000 | -24.3% | 4,885 | -2.5% | 0.09% | -25.4% |
| Q2 2016 | $506,000 | +5.6% | 5,012 | -0.8% | 0.12% | +2.5% |
| Q1 2016 | $479,000 | +0.2% | 5,054 | -1.8% | 0.12% | +3.5% |
| Q4 2015 | $478,000 | +9.9% | 5,149 | +0.9% | 0.12% | +1.8% |
| Q3 2015 | $435,000 | -22.6% | 5,103 | -22.2% | 0.11% | -22.1% |
| Q2 2015 | $562,000 | +2.2% | 6,563 | +1.2% | 0.14% | +2.8% |
| Q1 2015 | $550,000 | -1.4% | 6,482 | -0.4% | 0.14% | -2.8% |
| Q4 2014 | $558,000 | +13.2% | 6,507 | +0.4% | 0.14% | -1.4% |
| Q3 2014 | $493,000 | +0.4% | 6,482 | +4.0% | 0.15% | 0.0% |
| Q2 2014 | $491,000 | +5.1% | 6,232 | 0.0% | 0.15% | -3.9% |
| Q1 2014 | $467,000 | +89.8% | 6,232 | +95.3% | 0.15% | +84.3% |
| Q4 2013 | $246,000 | -10.5% | 3,191 | -19.5% | 0.08% | -3.5% |
| Q3 2013 | $275,000 | +27.3% | 3,965 | +15.9% | 0.09% | +13.2% |
| Q2 2013 | $216,000 | – | 3,420 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |